(UHS) Universal Health - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9139031002

UHS EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of UHS over the last 5 years for every Quarter.

UHS Revenue

This chart shows the Revenue of UHS over the last 5 years for every Quarter.

UHS: Hospitals, Medical Services, Behavioral Health, Insurance, Management Services

Universal Health Services Inc (NYSE:UHS) is a multifaceted healthcare provider operating through two primary segments: Acute Care Hospital Services and Behavioral Health Care Services. The companys diverse range of services includes general and specialty surgery, internal medicine, obstetrics, and emergency care, among others. Additionally, UHS provides commercial health insurance services and various management services such as central purchasing, information services, and physician recruitment to its subsidiaries and potentially external clients.

With a founding date of 1978 and headquartered in King of Prussia, Pennsylvania, UHS has established itself as a significant player in the healthcare industry. The companys operational footprint includes acute care hospitals and outpatient and behavioral health care facilities, indicating a broad reach into different aspects of healthcare provision.

Analyzing the available and , we can observe that UHS is currently trading at $189.09, slightly below its SMA20 at $190.07, but above its SMA50 at $182.40. The stock is also below its SMA200 at $196.42, suggesting a potential resistance level. The Average True Range (ATR) is 5.52, representing a 2.92% daily volatility. Given the 52-week high and low of $240.75 and $156.89, respectively, the stock is currently near the lower end of its recent trading range, potentially indicating an undervaluation.

From a fundamental perspective, UHS has a market capitalization of $12.17 billion and a P/E ratio of 10.60, with a forward P/E of 9.97. The Return on Equity (RoE) stands at 17.92%, suggesting a relatively strong profitability. Combining these insights, a forecast for UHS could involve a potential rebound from its current levels, driven by its undervaluation relative to its 52-week high and its robust RoE. If the stock can break through the SMA200 resistance at $196.42, it may be poised for further growth, potentially targeting the 52-week high of $240.75. However, a failure to break this resistance could result in continued volatility around the current price levels.

Based on the analysis, a possible trading strategy could involve monitoring UHS for a breakout above $196.42, with a potential target of $240.75, while keeping a close eye on the ATR for signs of increasing volatility that could either propel the stock upwards or downwards. Conversely, if the stock fails to gain traction and falls below its SMA50, it may signal a further decline, potentially towards the 52-week low.

Additional Sources for UHS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

UHS Stock Overview

Market Cap in USD 11,068m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 1990-03-26

UHS Stock Ratings

Growth Rating 33.5
Fundamental 70.7
Dividend Rating 34.7
Rel. Strength -1.09
Analysts 3.79 of 5
Fair Price Momentum 168.99 USD
Fair Price DCF 396.30 USD

UHS Dividends

Dividend Yield 12m 0.44%
Yield on Cost 5y 0.85%
Annual Growth 5y 31.95%
Payout Consistency 56.8%
Payout Ratio 4.5%

UHS Growth Ratios

Growth Correlation 3m 7.6%
Growth Correlation 12m -57.3%
Growth Correlation 5y 68.6%
CAGR 5y 12.84%
CAGR/Max DD 5y 0.29
Sharpe Ratio 12m 1.05
Alpha -15.95
Beta 0.536
Volatility 28.91%
Current Volume 1572.5k
Average Volume 20d 695.9k
What is the price of UHS shares?
As of June 23, 2025, the stock is trading at USD 171.70 with a total of 1,572,510 shares traded.
Over the past week, the price has changed by +0.79%, over one month by -7.91%, over three months by -5.34% and over the past year by -9.75%.
Is Universal Health a good stock to buy?
Yes, based on ValueRay´s Fundamental Analyses, Universal Health (NYSE:UHS) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.73 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UHS is around 168.99 USD . This means that UHS is currently overvalued and has a potential downside of -1.58%.
Is UHS a buy, sell or hold?
Universal Health has received a consensus analysts rating of 3.79. Therefor, it is recommend to hold UHS.
  • Strong Buy: 7
  • Buy: 1
  • Hold: 11
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for UHS share price target?
According to our own proprietary Forecast Model, UHS Universal Health will be worth about 182.9 in June 2026. The stock is currently trading at 171.70. This means that the stock has a potential upside of +6.52%.
Issuer Target Up/Down from current
Wallstreet Target Price 225.4 31.3%
Analysts Target Price 225.3 31.2%
ValueRay Target Price 182.9 6.5%